DK165696C - Desulfatohirudiner og deres farmaceutisk acceptable salte, deres fremstilling, farmaceutisk praeparat indeholdende disse forbindelser og anvendelse af forbindelserne til fremstilling af farmaceutisk middel og som analytisk reagens - Google Patents

Desulfatohirudiner og deres farmaceutisk acceptable salte, deres fremstilling, farmaceutisk praeparat indeholdende disse forbindelser og anvendelse af forbindelserne til fremstilling af farmaceutisk middel og som analytisk reagens

Info

Publication number
DK165696C
DK165696C DK552684A DK552684A DK165696C DK 165696 C DK165696 C DK 165696C DK 552684 A DK552684 A DK 552684A DK 552684 A DK552684 A DK 552684A DK 165696 C DK165696 C DK 165696C
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceutical
hirudines
desulphato
analytics
Prior art date
Application number
DK552684A
Other languages
English (en)
Other versions
DK552684D0 (da
DK552684A (da
DK165696B (da
Inventor
Hans Fritz
Johannes Dodt
Ursula Seemueller
Ernst Fink
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6214920&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK165696(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK552684D0 publication Critical patent/DK552684D0/da
Publication of DK552684A publication Critical patent/DK552684A/da
Publication of DK165696B publication Critical patent/DK165696B/da
Application granted granted Critical
Publication of DK165696C publication Critical patent/DK165696C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/26Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK552684A 1983-11-22 1984-11-21 Desulfatohirudiner og deres farmaceutisk acceptable salte, deres fremstilling, farmaceutisk praeparat indeholdende disse forbindelser og anvendelse af forbindelserne til fremstilling af farmaceutisk middel og som analytisk reagens DK165696C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3342139 1983-11-22
DE19833342139 DE3342139A1 (de) 1983-11-22 1983-11-22 Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel

Publications (4)

Publication Number Publication Date
DK552684D0 DK552684D0 (da) 1984-11-21
DK552684A DK552684A (da) 1985-05-23
DK165696B DK165696B (da) 1993-01-04
DK165696C true DK165696C (da) 1993-05-24

Family

ID=6214920

Family Applications (1)

Application Number Title Priority Date Filing Date
DK552684A DK165696C (da) 1983-11-22 1984-11-21 Desulfatohirudiner og deres farmaceutisk acceptable salte, deres fremstilling, farmaceutisk praeparat indeholdende disse forbindelser og anvendelse af forbindelserne til fremstilling af farmaceutisk middel og som analytisk reagens

Country Status (19)

Country Link
US (3) US4654302A (da)
EP (1) EP0142860B1 (da)
JP (1) JP2551551B2 (da)
AT (1) ATE56021T1 (da)
AU (1) AU578050B2 (da)
CA (1) CA1239606A (da)
CY (1) CY1737A (da)
DD (1) DD232498A5 (da)
DE (3) DE3342139A1 (da)
DK (1) DK165696C (da)
HK (1) HK121293A (da)
IE (1) IE57885B1 (da)
IL (1) IL73570A (da)
LU (1) LU90192I2 (da)
MX (1) MX9203370A (da)
NL (1) NL970045I2 (da)
NZ (1) NZ210275A (da)
PH (1) PH23831A (da)
ZA (1) ZA849068B (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
US5705355A (en) * 1984-03-27 1998-01-06 Transgene, S.A. Hirudin, pharmaceutical compositions comprising it and their use
FR2562088B1 (fr) * 1984-03-27 1987-11-13 Transgene Sa Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
ATE64956T1 (de) * 1984-06-14 1991-07-15 Ciba Geigy Ag Verfahren zur herstellung von thrombininhibitoren.
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
JPS6229997A (ja) * 1985-04-08 1987-02-07 Sankyo Co Ltd C末端にプロリンアミドを有するペプチドの製法
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
DE3689525D1 (de) * 1985-07-17 1994-02-24 Hoechst Ag Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel.
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
US5789540A (en) * 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US6005071A (en) * 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US5192745A (en) * 1987-05-21 1993-03-09 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5236898A (en) * 1987-05-21 1993-08-17 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
EP0333356A3 (en) * 1988-03-04 1990-12-19 Biogen, Inc. Hirudin peptides
AU614121B2 (en) * 1988-05-04 1991-08-22 Novartis Ag Improvements in the production of polypeptides
US4971953A (en) * 1988-05-10 1990-11-20 Merrell Dow Pharmaceuticals Anticoagulant peptide alcohols
EP0347376B1 (en) * 1988-06-11 1994-03-23 Ciba-Geigy Ag Novel polypeptides with an anticoagulant activity
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
GB8822147D0 (en) * 1988-09-21 1988-10-26 Ciba Geigy Ag Pharmaceutically active combination
HUT55799A (en) * 1988-09-29 1991-06-28 Biogen Inc Process for producing hirudine-like peptides
US4994367A (en) * 1988-10-07 1991-02-19 East Carolina University Extended shelf life platelet preparations and process for preparing the same
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
WO1990006128A1 (en) * 1988-12-05 1990-06-14 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
US6239101B1 (en) * 1989-07-05 2001-05-29 Oklahoma Medical Research Foundation Thrombin binding polypeptides
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
AU641215B2 (en) * 1990-02-13 1993-09-16 Merrell Dow Pharmaceuticals Inc. Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
DE4209110A1 (de) * 1991-11-26 1993-05-27 Basf Ag Neue thrombininhibitorische proteine aus landblutegeln
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
GB9401447D0 (en) * 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
KR20000070338A (ko) * 1997-01-20 2000-11-25 나가시마 카쭈시게, 노미야마 아키히코 펩티드의 안정화 방법 및 당해 방법을 이용한 펩티드 함유 동결건조 의약조성물
DE19755682A1 (de) * 1997-12-15 1999-06-17 Knoll Ag Verfahren zur Ermittlung eines Dosierungschemas für Thrombininhibitoren
DE10149678A1 (de) 2001-10-09 2009-03-12 Novel Science International Gmbh Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung
DE10301255A1 (de) 2003-01-15 2004-07-29 Cpi Creative Pharma International Gmbh Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel

Also Published As

Publication number Publication date
DK552684D0 (da) 1984-11-21
DK552684A (da) 1985-05-23
NL970045I2 (nl) 1998-08-03
DD232498A5 (de) 1986-01-29
DK165696B (da) 1993-01-04
CY1737A (en) 1995-10-20
EP0142860A2 (de) 1985-05-29
HK121293A (en) 1993-11-12
DE3342139A1 (de) 1985-05-30
NL970045I1 (nl) 1998-03-02
US4801576A (en) 1989-01-31
PH23831A (en) 1989-11-23
IE842979L (en) 1985-05-22
JP2551551B2 (ja) 1996-11-06
IE57885B1 (en) 1993-05-05
DE3483085D1 (de) 1990-10-04
MX9203370A (es) 1992-09-01
US4654302A (en) 1987-03-31
US4745177A (en) 1988-05-17
DE19775096I2 (de) 2002-07-04
CA1239606A (en) 1988-07-26
AU3575984A (en) 1985-05-30
AU578050B2 (en) 1988-10-13
JPS60136597A (ja) 1985-07-20
ZA849068B (en) 1985-07-31
LU90192I2 (fr) 1998-03-02
IL73570A0 (en) 1985-02-28
IL73570A (en) 1988-05-31
EP0142860A3 (en) 1987-03-11
NZ210275A (en) 1988-08-30
EP0142860B1 (de) 1990-08-29
ATE56021T1 (de) 1990-09-15

Similar Documents

Publication Publication Date Title
DK165696C (da) Desulfatohirudiner og deres farmaceutisk acceptable salte, deres fremstilling, farmaceutisk praeparat indeholdende disse forbindelser og anvendelse af forbindelserne til fremstilling af farmaceutisk middel og som analytisk reagens
DK164543C (da) Salte af l-carnitin og alkanoyl-l-carnitiner, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK83388D0 (da) Farmaceutisk middel indeholdende den insulin-lignende vaekstfaktor ii (igf-ii) til topisk anvendelse til saarheling
DK165195C (da) Fremgangsmaade til fremstilling af diperoxydodekandisyreholdige agglomerater og midler, i hvilke disse agglomerater anvendes som blegekomponent
DK573384A (da) Sphingosinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende disse derivater
DK165988C (da) Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c
NO871361D0 (no) Fremgangsmaate for redusering av fluidtap i sementsammensetninger som kan inneholde vesentlige saltkonsentrasjoner.
DK136781A (da) Diaminopyridiner og salte heraf fremgangsmaade til fremstillinng af disse og deres anvendelse som mellemprodukter
DK0558529T3 (da) Farmaceutisk præparat til behandling af forlænget koagulationstid
DK160981C (da) Arylsulfonylurinstof-derivater, fremgangsmaade til fremstilling deraf, anvendelse af disse som terapeutisk og antineoplastisk middel samt farmaceutiske midler indeholdende saadanne derivater
DK0471756T3 (da) Saccharinderivater, der er egnede som proteolytiske enzyminhibitorer, og fremstilling deraf
DK249386A (da) Benzoyl-urinstofderivater, fremgangsmaade til fremstilling af saadanne forbindelser og anvendelse af disse som insecticider
DK162231C (da) Phenolsulfonphthaleinyl-beta-d-galactosider, fremgangsmaade til deres fremstilling, anvendelse heraf til bestemmelse af beta-d-galactosidase samt et diagnostisk middel indeholdende disse
NO921382D0 (no) Amidinofenylalaninderivater, samt fremstilling, anvendelse og preparater inneholdende forbindelsene
FI813912L (fi) I laekemedel anvaendbara tricykliska cytosinderivat och foerfarande foer deras framstaellning
DK369280A (da) N-phenylpropylsubstituerede azoler samt fremgangsmaade til fremstilling af saadanne forbindelser og anvendelse af disse i fungicide midler
DK160296C (da) Acylerede naphthylaminer og salte og metalkomplekser deraf, middel indeholdende disse forbindelser samt deres anvendelse som plantefungicider
DK398483D0 (da) Substiuerede tert.butanolderivater, fremgangsmader til fremstilling deraf samt antimykotiske midler indeholdende disse forbindelser
DK453184D0 (da) 1-azolyl-substituerede oximethere, fremgangsmaade til fremstilling deraf og deres anvendelse som fungicider
DK4287D0 (da) Polyfluoralkylthiomethyl-forbindelser, fremgangsmaade til fremstilling deraf og anvendelse af saadanneforbindelser som overfladeaktive midler
DK585984D0 (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
DK630088A (da) Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel
DK0625351T3 (da) Anvendelse af etofibrat og farmaceutiske præparater indeholdende etofibrat til behandling af diabetisk angio- og retinopati
DK164548C (da) Azolylmethylpentanderivater, fremgangsmaade til deres fremstilling og landbrugs- og havebrugsmidler indeholdende disse som aktiv bestandel

Legal Events

Date Code Title Description
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1997 00045, 971120

PUP Patent expired